Availability of palliative care services in Zambia: A nationwide provincial and tertiary hospital survey by Utter, Brigitte Frett et al.
Availability of palliative care services in Zambia: A nationwide provincial
and tertiary hospital survey
Brigitte Frett Uttera, Groesbeck P. Parhamb,d, Claire-Helene Mershona, Kombatende Sikombea,
Agnes Musondaa, Jane Matamboa, Sharon Kapambwea, S. Citonje Msadabwec, Katundu Katundua,
Allen Batemana,b, Kennedy Lishimpic, Mulindi Mwanahamuntud, Carla J. Chibweshaa,b,⁎
a Centre for Infectious Disease Research in Zambia (CIDRZ), P.O. Box 34681, Lusaka, Zambia
bDivision of Global Women’s Health, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, 3009 Old Clinic Building
CB #7570, Chapel Hill, NC, 27599-7570, USA
c Cancer Diseases Hospital, Lusaka, Zambia
dUniversity of Zambia, P.O. Box 32379, Lusaka, Zambia





A B S T R A C T
Background: With high rates of HIV/AIDS and rising burdens of non-communicable diseases, Zambians in-
creasingly need palliative care. While efforts are underway to grow Zambia’s palliative care system, the most
recent situational analysis of palliative care in Zambia, conducted in 2008, revealed substantial gaps in avail-
ability.
Methods: To provide an updated appraisal of breast and cervical cancer services in Zambia, including palliative
care, we conducted a nationwide provincial and tertiary hospital survey. All 9 provincial hospitals and the
University Teaching Hospital and Cancer Diseases Hospital in Lusaka Province participated (N=11). The survey
was conducted between August 2014 and January 2015 and administered in-person at each facility. Data re-
garding the availability of inpatient, outpatient, and community-based palliative care services, palliative med-
ications, and psychosocial supports was obtained at each facility. The reported results are descriptive in nature.
Results: Although the need for palliative care services was recognized, many facilities (64%) lack palliative care
policies and only 18% offer palliative care in a coordinated program. The majority of services are only available
to inpatients and rarely include community-based programs. While all facilities had adequate supplies of acet-
aminophen, 82% reported unavailability of codeine and 45% reported no access to oral morphine.
Conclusions: This assessment confirms the dearth of palliative care services across Zambia. Less than half of its
provincial hospitals offer community- or home-based services and only 55% offer opioid analgesics. Immediate
and substantial improvements in policy, drug procurement and distribution, and service expansion are needed to
ensure high-quality palliative care is available throughout Zambia.
1. Introduction
Palliative care emphasizes improving quality of life through med-
ical, psychological, and spiritual services. These approaches are ap-
plicable to many diseases including cancer and HIV/AIDS [1,2]. Glob-
ally, palliative care models are associated with positive outcomes
including reduced symptom burden, increased quality of life, and im-
proved psychosocial wellbeing [3–6]. Unfortunately, the global need
for services far exceeds availability, this is especially true throughout
sub-Saharan Africa. While efforts to increase palliative care services
across Africa have led to improvements in care in the last 12 years, the
majority of African countries (52%) lack organized palliative care
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2. Methods
This analysis utilizes data from a facility assessment survey com-
pleted at all 9 provincial hospitals as well as the University Teaching
Hospital and Cancer Diseases Hospital in Lusaka (N=11). The survey
methods are described in detail in our prior publication of the primary
findings [8]. Briefly, facilities were chosen due to their priority listing
for service expansion in the Zambian National Cancer Control Strategic
Plan. At each facility, we administered an in-person survey to collect
self-reported data on human resources and facility infrastructure for
providing breast and cervical cancer services, including palliative care.
We also conducted a structured interview with each Provincial Health
Officer. A member of our research team traveled to each facility to
administer the survey and conduct key informant interviews.
The survey, developed by our team, examined three domains. The
first was the availability of and demand for palliative care. The avail-
ability domain included surveying facilities on the number and types of
healthcare providers available at that location as well as the availability
of specific services. As part of this domain, we also evaluated whether
patients seek palliative care and the settings where services are avail-
able. The second domain was an assessment of availability of psycho-
social and spiritual support for patients and families. The third domain
was the accessibility of palliative care medications. Medications were
selected from the International Association for Hospice and Palliative
Care List of Essential Medicines for Palliative Care. Stock-outs of key
medications were evaluated via self-report by asking: (1) in-stock
today, (2) out of stock today, (3) out of stock for 7 days, (4) out of stock
for 30 days, (5) out of stock for 90 days, (6) not available, or (7) don’t
know.
Descriptive analyses were performed using Microsoft Excel 2010
(Redmond, WA, U.S.A.). Regulatory approval was provided by the
Biomedical Research Ethics Committee of the University of Zambia (Ref
no. 009-06-14) and the Zambian Ministry of Health. Approvals included
a waiver of informed consent as our unit of analysis was the facility.
3. Results
Between August 2014 and January 2015, 11 Zambian hospitals
participated in our study. Our survey revealed a national average of 2
healthcare workers per 10,000 population, an estimate devised from
the total number of clinical providers (physicians, nurses, midwives,
pharmacists, and clinical officers) and population estimates. Eight fa-
cilities (72%) reported a demand for palliative care, with 4 (36%) re-
porting that patients often present seeking palliative care, 1 (9%) re-
porting that patients sometimes present seeking palliative care, and 3
(27%) reporting that patients rarely present seeking palliative care.
While 8 (72%) facilities provide inpatient palliative care, only 2 (18%)
provide coordinated services. Outpatient and home-based services are
offered by 4 (36%) and 3 (27%) of the facilities, respectively. Only 36%
of facilities reported having a policy for palliative care delivery.
As part of the service availability domain, we also assessed for
availability of counseling. All 11 facilities reported that they offer
psychosocial counseling, with 9 (82%) reporting staff trained in coun-
seling or bereavement but only 1 (9%) reporting that counseling is
provided by a psychiatrist or psychologist. The most common providers
of psychological counseling were nurses or midwives. Additionally, half
(55%) of facilities surveyed had chaplains. The final aspect of the ser-
vice domain assessed was whether facilities offer housing for patients
receiving palliative care services and the availability of community-
based care. While 10 (91%) facilities offer housing for palliative care
patients, only 2 (18%) offer community-based programs.
Under the medication domain, we assessed whether medications
indicated for (1) pain, (2) nausea/vomiting, (3) anorexia, and (4) de-
pression, anxiety, delirium, psychosis, and/or seizure were available.
All facilities reported that acetaminophen was available the day of the
survey, while 2 (18%) indicated that ibuprofen was out of stock. Seven
(64%) facilities reported that codeine was never available, while 45%
reported that morphine had been out of stock for 90 days. Most facil-
ities (10; 91%) reported that fentanyl, methadone, and oxycodone were
never available while seven (64%) indicated that senna was never
available. Three (27%) facilities reported stock-outs of dexamethasone
and prednisone, 1 (9%) reported stock-outs of carbamazepine, and 6
(55%) reported stock-outs of amitriptyline.
4. Discussion
The results of our health facility assessment reveal major gaps and
opportunities for improving the availability of palliative care services
across Zambia. As noted, only 36% of facilities reported having a policy
governing the provision of palliative care, highlighting the need for
national guidance on palliative care development throughout the
country. While inpatient palliative care services are accessible at the
majority of provincial-level facilities in Zambia, few offer outpatient or
home-based services. This is concerning for a number of reasons. First,
long distances and travel times to health facilities are known to affect
health-seeking behaviors [13,14]. Second, integrating palliative care
into communities is essential for expanding service availability. For
example, trained family members can meet the majority of palliative
care needs for patients at home and communities can take ownership of
palliative care programming, promoting sustainability [1]. There are
several models that can be considered as Zambia expands access to
community-based services, including community health worker models
currently in use in Malawi [2].
Our findings also indicate that inpatient services should be ex-
panded to meet a growing burden of chronic disease. While inpatient
palliative care is increasingly available in Zambia, it is not yet available
at all provincial-level facilities [10]. Given that 80% of cancer diag-
noses occur at advanced stages in developing countries and the cancer
burden continues to rise, the need for inpatient services will expand and
building capacity must be prioritized. Access to palliative care medi-
cations was also limited, including for inpatients. The WHO “pain
ladder” has been shown to provide adequate pain relief for most pa-
tients [15]. According to the ladder, the first step is to attempt pain
control with non-opioid medications. If pain remains untreated, oral
codeine can be used, followed by oral morphine. Unfortunately, the
majority of facilities surveyed reported that codeine is either never
available or was out-of-stock on the day of the survey. Additionally,
oral morphine was unavailable at nearly half of facilities. Since these
medications can be cheaply manufactured and procured, availability
must be addressed through centrally organized procedures.
To our knowledge, our survey is the first published assessment of
the availability of palliative care in Zambia that includes information
from each of Zambia’s provinces. It therefore provides a nationwide
services [7].
In Zambia, there is a generalized HIV/AIDS epidemic, the cervical 
cancer rate is the 5th highest in the world, and breast cancer is routinely 
diagnosed at advanced stages. Such a setting demands comprehensive 
palliative care services [8,9]. Although momentum is building, research 
indicates Zambia’s palliative care infrastructure remains weak [10,11].
According to the World Health Organization’s Public Health 
Strategy for expanding palliative care, key elements of national pal-
liative care programs include: policies, drug availability, education, and 
service implementation [12]. To obtain an overview of the availability 
of palliative care in Zambia, we completed an analysis of results from a 
nationwide, structured assessment documenting the availability of 
breast and cervical cancer screening, treatment, and care services in 
Zambia, including palliative care. The primary findings f rom this as-
sessment as well as an overview of the methodology utilized were 
published in this journal in 2017 [8]. Adding to that publication, we 
report here our findings s pecific to  pa lliative ca re, us ing th e WHO 
Public Health Strategy as a benchmark.
5. Conclusion
Palliative care is an essential healthcare service. Our findings de-
monstrate that while inpatient palliative care services are accessible at
72% of provincial-level facilities in Zambia, few facilities offer out-
patient or home-based services. Access to palliative care medications is
also limited. Implementation of a national framework that outlines
guidance for (1) inpatient, outpatient, and home-based services, (2)
educational programs, and (3) procurement of palliative care medica-
tions will be an important first step in expanding palliative care. Such a
national policy will lay the groundwork for program development,
ensuring that access to palliative care can expand throughout Zambia.
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appraisal of service availability and clarifies priority areas f or future 
programming. Although our survey covered the critical components of 
WHO’s Public Health Strategy as it relates to palliative care, it was 
limited in that only provincial and tertiary hospitals were included. As 
such, our findings may not b e g eneralizable t o l ower-level facilities. 
Importantly, all data were self-reported and none of the reported in-
formation was verified through observation of patient-provider inter-
actions or pharmacy stocks. This aspect of the study design may have 
introduced recall and reporting bias.
